 | Up a level |
Barbier, Michaela Carla; Fengler, Alicia; Pardo, Esther; Bhadhuri, Arjun; Meier, Niklaus; Gautschi, Oliver (2023). Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland. PharmacoEconomics, 41(12), pp. 1641-1655. Springer 10.1007/s40273-023-01305-3
Salari, Paola; Henrard, Séverine; O'Mahony, Cian; Welsing, Paco; Bhadhuri, Arjun; Jungo, Katharina Tabea; Beck, Thomas; O'Mahony, Denis; Byrne, Stephen; Spinewine, Anne; Knol, Wilma; Rodondi, Nicolas; Schwenkglenks, Matthias (2023). Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization. Health services insights, 16, p. 11786329231153278. Sage 10.1177/11786329231153278
Salari, Paola; O'Mahony, Cian; Henrard, Séverine; Welsing, Paco; Bhadhuri, Arjun; Schur, Nadine; Roumet, Marie; Beglinger, Shanthi; Beck, Thomas; Jungo, Katharina Tabea; Byrne, Stephen; Hossmann, Stefanie; Knol, Wilma; O'Mahony, Denis; Spinewine, Anne; Rodondi, Nicolas; Schwenkglenks, Matthias (2022). Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study. PLoS ONE, 17(4), e0265507. Public Library of Science 10.1371/journal.pone.0265507
Bhadhuri, Arjun; Kind, Paul; Salari, Paola; Jungo, Katharina Tabea; Boland, Benoît; Byrne, Stephen; Hossmann, Stefanie; Dalleur, Olivia; Knol, Wilma; Moutzouri, Elisavet; O'Mahony, Denis; Murphy, Kevin D; Wisselink, Linda; Rodondi, Nicolas; Schwenkglenks, Matthias (2020). Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Health and quality of life outcomes, 18(1), p. 317. BioMed Central 10.1186/s12955-020-01564-0
